Results 71 to 80 of about 2,117 (104)

Radon exposure and COVID-19 mortality in pre-vaccination period: What links might exist? [PDF]

PLoS One
Coudert JF, Dadachova E, Maignant G, Jonathan S.   +3 more
europepmc   +1 more source

Sex Differences in Parkinson's Disease: A Narrative Review. [PDF]

Neurol Ther
Cattaneo C, Pagonabarraga J.
europepmc   +1 more source

Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons. [PDF]

Ann Clin Transl Neurol
McDonald CM, Guglieri M, Vučinić D, Acsadi G, Brandsema JF, Bruno C, Finanger EL, Harper A, Lobato ML, Masson R, Muelas N, Munell F, Nevo Y, Péréon Y, Phan H, Sansone VA, Scoto M, Willis T, Finkel RS, Vandenborne K, Cazzaniga S, Montrasio S, Alessi F, Bettica P, Mercuri E, Givinostat Study 51 Investigators, Cooperative International Neuromuscular Research Group (CINRG) Duchenne Natural History Study (DNHS) Investigators, ImagingDMD Investigators.   +27 more
europepmc   +1 more source

Gym entry fees act as a barrier to exercising in community gyms for young adults with disability: A mixed methods study. [PDF]

JSAMS Plus
Kennedy RA, McKenzie G, Shields N.
europepmc   +1 more source

Upadacitinib for the treatment of radiographic axial spondyloarthritis - case series and review of the literature. [PDF]

Drugs Context
Lopalco G, D'Antonio A, Chimenti MS, Iannone F.   +3 more
europepmc   +1 more source

PEGylated Proteins: How Much Does Molecular Weight Matter? [PDF]

Clin Pharmacokinet
Fornasari DMM.
europepmc   +1 more source

A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy. [PDF]

Clinicoecon Outcomes Res
Luminari S, Pinto A, Puccini B, D'Arpino A, Omodeo Salè E, Bellone M, Pradelli L, Sabinot A.   +7 more
europepmc   +1 more source